Creative Medical Technology Holdings, Inc.
CELZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001187953
No open-market purchases or sales by Creative Medical Technology Holdings, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $540.7K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Creative Medical Technology Holdings, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 10 | 8 | −2 |
| Shares | 69.2K | 29.9K | −39.3K (−56.8%) |
| Value | $213.8K | $71.2K | −$142.5K (−66.7%) |
New holders (1)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Geode Capital Management, LLC | 10,308 | $24.7K | 0.00% |
Sold out (3)
Institutions that held Creative Medical Technology Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Aaron Wealth Advisors | 19,570 | $60.7K |
| Two Sigma Advisers, LP | 14,500 | $44.9K |
| Two Sigma Investments, LP | 13,106 | $40.6K |